Intravitreal dexamethasone insert in diabetic macular edema super-refractory to anti-vascular endothelial growth factor therapy.

Carl S WilkinsEthan K SobolGareth Mc LemaJessica G LeeRichard B RosenAvnish Deobhakta

Published in: European journal of ophthalmology (2021)

Intravitreal dexamethasone insert appears effective in eyes with super-refractory DME. IDI resulted in excellent anatomic improvement on SD-OCT as well as modest visual improvement. Injection burden was reduced in those who may otherwise receive years of monthly treatments.

Keyphrases

vascular endothelial growth factor
optical coherence tomography
high dose
low dose
endothelial cells
diabetic retinopathy
stem cells
cataract surgery
smoking cessation